Manufacturing News of Note: Catalent expands; Hospira and Novartis issue recalls

stocks
(Pixabay)

> Catalent is investing $9 million in a clinical supply facility in San Diego, California. Release

> Nichi-Iko Pharmaceutical, parent of Sagent Pharmaceuticals, says its Canadian subsidiary, Omega Laboratories, has won FDA approval for its site in Montreal to manufacture products for the U.S. Release

> Pfizer's Hospira is voluntarily recalling one lot of bacteriostatic water used to dilute drugs because vials may not be sterile and bring a risk of bacterial infections. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> Novartis is recalling one lot of asthma med Xolair in Canada because the vials may include silicone oil. Release

Suggested Articles

A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Zantac and some OTC antacids.

Civica Rx, which last week hit its first anniversary, continues to strike deals that will help it to battle shortages and high costs for its healthcare members…

An Ipca Labs plant savaged in an FDA warning letter three years ago continues to fail manufacturing standards that would assure its drugs are safe.